Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alienys Izquierdo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 30, 2010
Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disordersGissel García, Narjara González, Ana Beatriz Pérez, et al.
The American Journal of Tropical Medicine and Hygiene|June 4, 2010
Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphismGissel García, Beatriz Sierra, Ana B Pérez, et al.
Virus Genes|May 24, 2014
Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine designRosa Ramírez, Rosabel Falcón, Alienys Izquierdo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and MonkeysLázaro Gil, Karem Cobas, Laura Lazo, et al.
International Immunology|March 22, 2015
A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeysEdith Suzarte, Lázaro Gil, Iris Valdés, et al.
Immunology and Cell Biology|September 3, 2014
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2Lázaro Gil, Ernesto Marcos, Alienys Izquierdo, et al.
Immunology Letters|May 29, 2016
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune responseErnesto Marcos, Laura Lazo, Lázaro Gil, et al.
The Journal of General Virology|May 16, 2019
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccineIris Valdés, Alienys Izquierdo, Karem Cobas, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 30, 2010
Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disordersGissel García, Narjara González, Ana Beatriz Pérez, et al.
The American Journal of Tropical Medicine and Hygiene|June 4, 2010
Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphismGissel García, Beatriz Sierra, Ana B Pérez, et al.
Virus Genes|May 24, 2014
Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine designRosa Ramírez, Rosabel Falcón, Alienys Izquierdo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and MonkeysLázaro Gil, Karem Cobas, Laura Lazo, et al.
International Immunology|March 22, 2015
A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeysEdith Suzarte, Lázaro Gil, Iris Valdés, et al.
Immunology and Cell Biology|September 3, 2014
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2Lázaro Gil, Ernesto Marcos, Alienys Izquierdo, et al.
Immunology Letters|May 29, 2016
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune responseErnesto Marcos, Laura Lazo, Lázaro Gil, et al.
The Journal of General Virology|May 16, 2019
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccineIris Valdés, Alienys Izquierdo, Karem Cobas, et al.
Pageof 2